Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2007

01-01-2007

“Spicing Up” of the Immune System by Curcumin

Authors: Ganesh Chandra Jagetia, Bharat B. Aggarwal

Published in: Journal of Clinical Immunology | Issue 1/2007

Login to get access

Abstract

Curcumin (diferuloylmethane) is an orange-yellow component of turmeric (Curcuma longa), a spice often found in curry powder. Traditionally known for its an antiinflammatory effects, curcumin has been shown in the last two decades to be a potent immunomodulatory agent that can modulate the activation of T cells, B cells, macrophages, neutrophils, natural killer cells, and dendritic cells. Curcumin can also downregulate the expression of various proinflammatory cytokines including TNF, IL-1, IL-2, IL-6, IL-8, IL-12, and chemokines, most likely through inactivation of the transcription factor NF-κB. Interestingly, however, curcumin at low doses can also enhance antibody responses. This suggests that curcumin’s reported beneficial effects in arthritis, allergy, asthma, atherosclerosis, heart disease, Alzheimer’s disease, diabetes, and cancer might be due in part to its ability to modulate the immune system. Together, these findings warrant further consideration of curcumin as a therapy for immune disorders.
Literature
1.
go back to reference Dobelis Hamper IN (ed): Magic and Medicine of Plants. Pleasantville, NY, Reader’s Digest Association, 1986 Dobelis Hamper IN (ed): Magic and Medicine of Plants. Pleasantville, NY, Reader’s Digest Association, 1986
2.
go back to reference Srimal RC, Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25(6):447–452, 1973PubMed Srimal RC, Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25(6):447–452, 1973PubMed
3.
go back to reference Jain SK, DeFilipps RA: Medicinal Plants of India. Algonac, MI, Reference, 1991, p 120 Jain SK, DeFilipps RA: Medicinal Plants of India. Algonac, MI, Reference, 1991, p 120
4.
go back to reference Nadkarni AK: Indian Materia Medica, Vol 1. Bombay, India, Popular Book Depot, 1954 Nadkarni AK: Indian Materia Medica, Vol 1. Bombay, India, Popular Book Depot, 1954
5.
go back to reference Chang HM, But BPH: Pharmacology and Applications of Chinese Materia Medica, Vol 2. Philadelphia, PA, World Scientific, 1986, pp 936–939 Chang HM, But BPH: Pharmacology and Applications of Chinese Materia Medica, Vol 2. Philadelphia, PA, World Scientific, 1986, pp 936–939
6.
go back to reference Tu G, Fang Q, Guo J, Yuan S, Chen C, Chen J, Chen Z, Cheng S, Jin R, Li M, et al.: Pharmacopoeia of the People’s Republic of China. Guangzhou, P.R. China, Guangdong Science and Technology Press, 1992, pp 202–203 Tu G, Fang Q, Guo J, Yuan S, Chen C, Chen J, Chen Z, Cheng S, Jin R, Li M, et al.: Pharmacopoeia of the People’s Republic of China. Guangzhou, P.R. China, Guangdong Science and Technology Press, 1992, pp 202–203
7.
go back to reference Leung A: Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, Wiley, 1980, pp 313–314 Leung A: Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, Wiley, 1980, pp 313–314
8.
go back to reference Lampe V, Milobedeska J, Kostanecki V: Ber Dtsch Chem Ges 43:2163, 1910 Lampe V, Milobedeska J, Kostanecki V: Ber Dtsch Chem Ges 43:2163, 1910
9.
go back to reference Lampe V, Milobedeska J: Ber Dtsch Chem Ges 46:2235, 1913 Lampe V, Milobedeska J: Ber Dtsch Chem Ges 46:2235, 1913
10.
go back to reference Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 57(1):1–7, 1991PubMed Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 57(1):1–7, 1991PubMed
11.
go back to reference Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21(4B):2895–2900, 2001PubMed Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21(4B):2895–2900, 2001PubMed
12.
go back to reference Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10, 2006PubMed Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10, 2006PubMed
13.
go back to reference Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15(12):1867–1876, 1997PubMed Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15(12):1867–1876, 1997PubMed
14.
go back to reference Wang F, Wu X, Wang F, Liu S, Jia Z, Yang J: The sensitive method for the determination of curcumin using the enhancement of mixed micelle. J Fluoresc 16(1):53–59, 2006PubMed Wang F, Wu X, Wang F, Liu S, Jia Z, Yang J: The sensitive method for the determination of curcumin using the enhancement of mixed micelle. J Fluoresc 16(1):53–59, 2006PubMed
15.
go back to reference Arora R, Kapoor V, Basu N, Jain AP: Anti-inflammatory studies on Curcuma longa (turmeric). Ind J Med Res 59:1289–1295, 1971 Arora R, Kapoor V, Basu N, Jain AP: Anti-inflammatory studies on Curcuma longa (turmeric). Ind J Med Res 59:1289–1295, 1971
16.
go back to reference Mukhopadhyay A, Basu N, Ghatak N: Anti-inflammatory and irritant activities of curcumin analogues rats. Agents Actions 12:508–515, 1982PubMed Mukhopadhyay A, Basu N, Ghatak N: Anti-inflammatory and irritant activities of curcumin analogues rats. Agents Actions 12:508–515, 1982PubMed
17.
go back to reference Srivastava R: Inhibition of neutrophil response by curcumin. Agents Actions 28:298–303, 1989PubMed Srivastava R: Inhibition of neutrophil response by curcumin. Agents Actions 28:298–303, 1989PubMed
18.
go back to reference Jobin C, Bradham CA, Russo MP, Juma, B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated Nfkappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163:3474–3483, 1999PubMed Jobin C, Bradham CA, Russo MP, Juma, B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated Nfkappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163:3474–3483, 1999PubMed
19.
go back to reference Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK: Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J Agric Food Chem 47:4297–4300, 1999PubMed Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK: Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J Agric Food Chem 47:4297–4300, 1999PubMed
20.
go back to reference Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmcol 49:1165–1170, 1995 Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmcol 49:1165–1170, 1995
21.
go back to reference Bourne KZ, Bourne N, Reising SF, Stanberry LR: Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antivir Res 42:219–226, 1999PubMed Bourne KZ, Bourne N, Reising SF, Stanberry LR: Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antivir Res 42:219–226, 1999PubMed
22.
go back to reference Apisariyakul A, Vanittanakom N, Buddhasukh D: Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 49:163–169, 1995PubMed Apisariyakul A, Vanittanakom N, Buddhasukh D: Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 49:163–169, 1995PubMed
23.
go back to reference Reddy AC, Lokesh BR: Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. Toxicology 107(1):39–45, 1996PubMed Reddy AC, Lokesh BR: Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. Toxicology 107(1):39–45, 1996PubMed
24.
go back to reference Ramsewak RS, DeWitt DL, Nair MG: Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7:303–308, 2000PubMed Ramsewak RS, DeWitt DL, Nair MG: Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7:303–308, 2000PubMed
25.
go back to reference Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R: Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83, 1995PubMed Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R: Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83, 1995PubMed
26.
go back to reference Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V: Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci 28(6):715–721, 2003PubMed Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V: Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci 28(6):715–721, 2003PubMed
27.
go back to reference Garg AK, Buchholz TA, Aggarwal BB: Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 7(11–12):1630–1647, 2005PubMed Garg AK, Buchholz TA, Aggarwal BB: Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 7(11–12):1630–1647, 2005PubMed
28.
go back to reference Abraham SK, Sarma L, Kesavan PC: Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. Mutat Res 303(3):109–112, 1993PubMed Abraham SK, Sarma L, Kesavan PC: Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. Mutat Res 303(3):109–112, 1993PubMed
29.
go back to reference Rezvani M, Ross GA: Modification of radiation-induced acute oral mucositis in the rat. Int J Radiat Biol 80(2):177–182, 2004PubMed Rezvani M, Ross GA: Modification of radiation-induced acute oral mucositis in the rat. Int J Radiat Biol 80(2):177–182, 2004PubMed
30.
go back to reference Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM: Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:1599–1607, 2004PubMed Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM: Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:1599–1607, 2004PubMed
31.
go back to reference Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE: Curcumin: A new radiosensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132:317–321, 2005PubMed Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE: Curcumin: A new radiosensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132:317–321, 2005PubMed
32.
go back to reference Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC, Maheshwari RK: Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6:167–177, 1998PubMed Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC, Maheshwari RK: Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6:167–177, 1998PubMed
33.
go back to reference Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK: Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7:362–374, 1999PubMed Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK: Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7:362–374, 1999PubMed
34.
go back to reference Jiang MC, Yang-Yen HF, Yen JJ, Lin JK: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26:111–120, 1996PubMed Jiang MC, Yang-Yen HF, Yen JJ, Lin JK: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26:111–120, 1996PubMed
35.
go back to reference Huang M-T, Lou RY, Ma W, Newmark HL, Reuhl KR, Conney AH: Inhibitory effects of dietary curcumin on forestomach duodenal and colon carcinogenesis in mice. Cancer Res 54:5841–5847, 1994PubMed Huang M-T, Lou RY, Ma W, Newmark HL, Reuhl KR, Conney AH: Inhibitory effects of dietary curcumin on forestomach duodenal and colon carcinogenesis in mice. Cancer Res 54:5841–5847, 1994PubMed
36.
go back to reference Huang M-T, Smart RC, Wong CQ, Conney AH: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoyl phorbol-13-acetate. Cancer Res 48:5941–5946, 1988PubMed Huang M-T, Smart RC, Wong CQ, Conney AH: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoyl phorbol-13-acetate. Cancer Res 48:5941–5946, 1988PubMed
37.
go back to reference Wang ZY, Georgiadis CA, Laskin JD, Conney AH: Inhibitory effects of curcumin on tumor initiation by benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene. Carcinogenesis 54:5841–5847, 1992 Wang ZY, Georgiadis CA, Laskin JD, Conney AH: Inhibitory effects of curcumin on tumor initiation by benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene. Carcinogenesis 54:5841–5847, 1992
38.
go back to reference Rao CV, Rivenson A, Simi B, Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259–266, 1995PubMed Rao CV, Rivenson A, Simi B, Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259–266, 1995PubMed
39.
go back to reference Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA: Effects of the phytochemicals, curcumin and quercetin upon azoxymethane induced colon cancer and 7,12 dimethylbenz(a)anthracene induced mammary cancer in rats. Carcinogenesis 17:1305–1311, 1996PubMed Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA: Effects of the phytochemicals, curcumin and quercetin upon azoxymethane induced colon cancer and 7,12 dimethylbenz(a)anthracene induced mammary cancer in rats. Carcinogenesis 17:1305–1311, 1996PubMed
40.
go back to reference Bhide SV, Azuine MA, Lahiri M, Telang NT: Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products. Breast Cancer Res Treat 30:233–242, 1994PubMed Bhide SV, Azuine MA, Lahiri M, Telang NT: Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products. Breast Cancer Res Treat 30:233–242, 1994PubMed
41.
go back to reference Singletary K, MacDonald C, Wallig M, Fischer C: Inhibition of 7,12-dimethylbenz(a) anthracene (DMBA) induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103:137–141, 1996PubMed Singletary K, MacDonald C, Wallig M, Fischer C: Inhibition of 7,12-dimethylbenz(a) anthracene (DMBA) induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103:137–141, 1996PubMed
42.
go back to reference Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME: Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405–10412, 2000PubMed Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME: Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405–10412, 2000PubMed
43.
go back to reference Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ: Chemopreventive efficacy and pharmacokinetics of curcumin in the min/ +mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11(6):535–540, 2002PubMed Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ: Chemopreventive efficacy and pharmacokinetics of curcumin in the min/ +mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11(6):535–540, 2002PubMed
44.
go back to reference Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R: Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104(4):879–890, 2005PubMed Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R: Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104(4):879–890, 2005PubMed
45.
go back to reference Holy JM: Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518:71–84, 2002PubMed Holy JM: Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518:71–84, 2002PubMed
46.
go back to reference Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512:334–340, 2002PubMed Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512:334–340, 2002PubMed
47.
go back to reference Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363–398, 2003PubMed Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363–398, 2003PubMed
48.
go back to reference LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB: Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11(19 Pt 1):6994–7002, 2005PubMed LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB: Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11(19 Pt 1):6994–7002, 2005PubMed
49.
go back to reference Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M: Curcumin inhibits mitogen stimulated lymphocyte proliferation, NF-κB activation, and IL-2 signaling. J Surg Res 121(2):171–177, 2004PubMed Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M: Curcumin inhibits mitogen stimulated lymphocyte proliferation, NF-κB activation, and IL-2 signaling. J Surg Res 121(2):171–177, 2004PubMed
50.
go back to reference Ranjan D, Johnston TD, Wu G, Elliott L, Bondada S, Nagabhushan M: Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J Surg Res 77(2):174–178, 1998PubMed Ranjan D, Johnston TD, Wu G, Elliott L, Bondada S, Nagabhushan M: Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J Surg Res 77(2):174–178, 1998PubMed
51.
go back to reference Yadav VS, Mishra KP, Singh DP, Mehrotra S, Singh VK: Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27:485–497, 2005PubMed Yadav VS, Mishra KP, Singh DP, Mehrotra S, Singh VK: Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27:485–497, 2005PubMed
52.
go back to reference Cipriani B, Borsellino G, Knowles H, Tramonti D, Cavaliere F, Bernardi G, Battistini L, Brosnan CF: Curcumin inhibits activation of Vγ9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol 167(6):3454–3462, 2001PubMed Cipriani B, Borsellino G, Knowles H, Tramonti D, Cavaliere F, Bernardi G, Battistini L, Brosnan CF: Curcumin inhibits activation of Vγ9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol 167(6):3454–3462, 2001PubMed
53.
go back to reference Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J, Radziszewska E: Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54(8):899–907, 1997PubMed Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J, Radziszewska E: Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54(8):899–907, 1997PubMed
54.
go back to reference Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Mori N: Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30(3):313–321, 2006PubMed Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Mori N: Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30(3):313–321, 2006PubMed
55.
go back to reference Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N: Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118:765–772, 2006PubMed Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N: Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118:765–772, 2006PubMed
56.
go back to reference Li X, Liu X: Effect of curcumin on immune function of mice. J Huazhong Univ Sci Technol Med Sci 25(2):137–140, 2005PubMedCrossRef Li X, Liu X: Effect of curcumin on immune function of mice. J Huazhong Univ Sci Technol Med Sci 25(2):137–140, 2005PubMedCrossRef
57.
go back to reference Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM: Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89:169–175, 2000PubMed Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM: Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89:169–175, 2000PubMed
58.
go back to reference Gertsch J, Guttinger M, Heilmann J, Sticher O: Curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells. Bioorg Med Chem 11(6):1057–1063, 2003PubMed Gertsch J, Guttinger M, Heilmann J, Sticher O: Curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells. Bioorg Med Chem 11(6):1057–1063, 2003PubMed
59.
go back to reference Kuramoto Y, Yamada K, Tsuruta O, Sugano M: Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. Biosci Biotechnol Biochem 60(10):1712–1713, 1996PubMed Kuramoto Y, Yamada K, Tsuruta O, Sugano M: Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. Biosci Biotechnol Biochem 60(10):1712–1713, 1996PubMed
60.
go back to reference Cohly HHP, Rao MR, Kanji VK, Patlolla B, Taylor A, Wilson MT, Angel MF, Das SK: Effect of turmeric, turmerin, and curcumin on Ca2+, Na/K+ ATPases in concanavalin A-stimulated human blood mononuclear cells. Int J Mol Sci 4:34–44, 2003CrossRef Cohly HHP, Rao MR, Kanji VK, Patlolla B, Taylor A, Wilson MT, Angel MF, Das SK: Effect of turmeric, turmerin, and curcumin on Ca2+, Na/K+ ATPases in concanavalin A-stimulated human blood mononuclear cells. Int J Mol Sci 4:34–44, 2003CrossRef
61.
go back to reference Ranjan D, Siquijor A, Johnston TD, Wu G, Nagabhuskahn M: The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am Surg 64(1):47–51, 1998PubMed Ranjan D, Siquijor A, Johnston TD, Wu G, Nagabhuskahn M: The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am Surg 64(1):47–51, 1998PubMed
62.
go back to reference Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S: Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93:152–161, 1999PubMed Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S: Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93:152–161, 1999PubMed
63.
go back to reference Joe B, Lokesh BR: Role of capsaicin, curcumin and dietary n − 3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224(2):255–263, 1994PubMed Joe B, Lokesh BR: Role of capsaicin, curcumin and dietary n − 3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224(2):255–263, 1994PubMed
64.
go back to reference Joe B, Lokesh BR: Dietary n − 3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages. Mol Cell Biochem 203(1–2):153–161, 2000PubMed Joe B, Lokesh BR: Dietary n − 3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages. Mol Cell Biochem 203(1–2):153–161, 2000PubMed
65.
go back to reference Bhaumik S, Jyothi MD, Khar A: Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483:78–82, 2000PubMed Bhaumik S, Jyothi MD, Khar A: Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483:78–82, 2000PubMed
66.
go back to reference South EH, Exon JH, Hendrix K: Dietary curcumin enhances antibody response in rats. Immunopharmacol Immunotoxicol 19(1):105–119, 1997PubMed South EH, Exon JH, Hendrix K: Dietary curcumin enhances antibody response in rats. Immunopharmacol Immunotoxicol 19(1):105–119, 1997PubMed
67.
go back to reference Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68:51–61, 2004PubMed Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68:51–61, 2004PubMed
68.
go back to reference Kim K, Ryu K, Ko Y, Park C: Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br J Haematol 131(1):59–66, 2005PubMed Kim K, Ryu K, Ko Y, Park C: Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br J Haematol 131(1):59–66, 2005PubMed
69.
go back to reference Crowley M, Inaba K, Steinman RM: Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 172:383–386, 1990PubMed Crowley M, Inaba K, Steinman RM: Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 172:383–386, 1990PubMed
70.
go back to reference Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296, 1991PubMed Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296, 1991PubMed
71.
go back to reference Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen-presenting function of dendritic cells. Curr Opin Immunol 9:10–16, 1997PubMed Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen-presenting function of dendritic cells. Curr Opin Immunol 9:10–16, 1997PubMed
72.
go back to reference Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245–252, 1998PubMed Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245–252, 1998PubMed
73.
go back to reference Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, Lee CM, Ahn SC, Park YC, Park YM: Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174(12):8116–8124, 2005PubMed Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, Lee CM, Ahn SC, Park YC, Park YM: Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174(12):8116–8124, 2005PubMed
74.
go back to reference Srivastava R: Inhibition of neutrophil response by curcumin. Agents Actions 28(3–4):298–303, 1989PubMed Srivastava R: Inhibition of neutrophil response by curcumin. Agents Actions 28(3–4):298–303, 1989PubMed
75.
go back to reference Antony S, Kuttan R, Kuttan G: Immunomodulatory activity of curcumin. Immunol Invest 28(5–6):291–303, 1999PubMed Antony S, Kuttan R, Kuttan G: Immunomodulatory activity of curcumin. Immunol Invest 28(5–6):291–303, 1999PubMed
76.
go back to reference Ju HR, Wu HY, Nishizono S, Sakono M, Ikeda I, Sugano M, Imaizumi K: Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. Biosci Biotechnol Biochem 60(11):1856–1860, 1996PubMedCrossRef Ju HR, Wu HY, Nishizono S, Sakono M, Ikeda I, Sugano M, Imaizumi K: Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. Biosci Biotechnol Biochem 60(11):1856–1860, 1996PubMedCrossRef
77.
go back to reference Flynn DL, Rafferty MF, Boctor AM: Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22(3):357–360, 1986PubMed Flynn DL, Rafferty MF, Boctor AM: Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22(3):357–360, 1986PubMed
78.
go back to reference Bielak-Zmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E: Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38(1):131–138, 2000PubMed Bielak-Zmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E: Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38(1):131–138, 2000PubMed
79.
go back to reference Chan MM: Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49(11):1551–1556, 1995PubMed Chan MM: Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49(11):1551–1556, 1995PubMed
80.
go back to reference Lantz RC, Chena GJ, Solyomb AM, Jolad SD, Timmermann BN: The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12:445–452, 2005PubMed Lantz RC, Chena GJ, Solyomb AM, Jolad SD, Timmermann BN: The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12:445–452, 2005PubMed
81.
go back to reference Lee JJ, Huang WT, Shao DZ, Liao JF, Lin MT: Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol 53(5):367–375, 2003PubMed Lee JJ, Huang WT, Shao DZ, Liao JF, Lin MT: Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol 53(5):367–375, 2003PubMed
82.
go back to reference Abe Y, Hashimoto S, Horie T: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41–47, 1999PubMed Abe Y, Hashimoto S, Horie T: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41–47, 1999PubMed
83.
go back to reference Moon DO, Jin CY, Lee JD, Choi YH, Ahn SC, Lee CM, Jeong SC, Park YM, Kim GY: Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: Suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol Pharm Bull 29(7):1470–1475, 2006PubMed Moon DO, Jin CY, Lee JD, Choi YH, Ahn SC, Lee CM, Jeong SC, Park YM, Kim GY: Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: Suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol Pharm Bull 29(7):1470–1475, 2006PubMed
84.
go back to reference Gulcubuk A, Altunatmaz K, Sonmez K, Haktanir-Yatkin D, Uzun H, Gurel A, Aydin S: Effects of curcumin on tumour necrosis factor-α and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med 53:49–54, 2006PubMed Gulcubuk A, Altunatmaz K, Sonmez K, Haktanir-Yatkin D, Uzun H, Gurel A, Aydin S: Effects of curcumin on tumour necrosis factor-α and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med 53:49–54, 2006PubMed
85.
go back to reference Gaddipati JP, Sundar SV, Calemine J, Seth P, Sidhu GS, Maheshwari RK: Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19(2):150–156, 2003PubMed Gaddipati JP, Sundar SV, Calemine J, Seth P, Sidhu GS, Maheshwari RK: Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19(2):150–156, 2003PubMed
86.
go back to reference Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, Wang P: The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ. Crit Care Med 34(7):1874–1882, 2006PubMed Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, Wang P: The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ. Crit Care Med 34(7):1874–1882, 2006PubMed
87.
go back to reference Jang MK, Sohn DH, Ryu JH: A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67(6):550–552, 2001PubMed Jang MK, Sohn DH, Ryu JH: A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67(6):550–552, 2001PubMed
88.
go back to reference Deeb D, Xu YX, Jiang H, Gao X, Janakiraman N, Chapman RA, Gautam SC: Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2:95–103, 2003PubMed Deeb D, Xu YX, Jiang H, Gao X, Janakiraman N, Chapman RA, Gautam SC: Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2:95–103, 2003PubMed
89.
go back to reference Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-{kappa}B through suppression of I{kappa}B{alpha} phosphorylation. Mol Cancer Ther 3(7):803–812, 2004PubMed Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-{kappa}B through suppression of I{kappa}B{alpha} phosphorylation. Mol Cancer Ther 3(7):803–812, 2004PubMed
90.
go back to reference Jung E, Park MJ, Choi KS, Park J-W, Lee HI, Lee KS, Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis- inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 27(10):2008–2017, 2006PubMed Jung E, Park MJ, Choi KS, Park J-W, Lee HI, Lee KS, Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis- inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 27(10):2008–2017, 2006PubMed
91.
go back to reference Jung EM, Lim JH, Lee TJ, Park J-W, Choi KS, Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26:1905–1913, 2005PubMed Jung EM, Lim JH, Lee TJ, Park J-W, Choi KS, Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26:1905–1913, 2005PubMed
92.
go back to reference Terry CM, Clikeman JA, Hoidal JR, Callahan KS: Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol Heart Circ Physiol 274(43):H883–H891, 1998 Terry CM, Clikeman JA, Hoidal JR, Callahan KS: Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol Heart Circ Physiol 274(43):H883–H891, 1998
93.
go back to reference Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda O, Mita S, Setoguchi T, Ogawa M: Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95:1206–1214, 2002PubMed Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda O, Mita S, Setoguchi T, Ogawa M: Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95:1206–1214, 2002PubMed
94.
go back to reference Wang X, Wang Q, Ives KL, Ever BM: Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res 12(18):5356–5355, 2006 Wang X, Wang Q, Ives KL, Ever BM: Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res 12(18):5356–5355, 2006
95.
go back to reference Renard P, Delaive E, Van Steenbrugge M, Remacle J, Raes M: Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation? Antioxid Redox Signal 3:329–340, 2001PubMed Renard P, Delaive E, Van Steenbrugge M, Remacle J, Raes M: Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation? Antioxid Redox Signal 3:329–340, 2001PubMed
96.
go back to reference Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163(6):3474–3483, 1999PubMed Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163(6):3474–3483, 1999PubMed
97.
go back to reference Chaudhary LR, Avioli LV: Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 271:16591–16596, 1996PubMed Chaudhary LR, Avioli LV: Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 271:16591–16596, 1996PubMed
98.
go back to reference Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS: Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384(2–3):191–195, 1999PubMed Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS: Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384(2–3):191–195, 1999PubMed
99.
go back to reference Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, Kim TS: Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128(2):380–384, 1999PubMed Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, Kim TS: Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128(2):380–384, 1999PubMed
100.
go back to reference Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 21:335–376, 2003PubMed Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 21:335–376, 2003PubMed
101.
go back to reference Youn HS, Saitoh SI, Miyake K, Hwang DH: Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72(1):62–69, 2006PubMed Youn HS, Saitoh SI, Miyake K, Hwang DH: Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72(1):62–69, 2006PubMed
102.
go back to reference Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, Matsuo S: Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 15:1289–1299, 2004PubMed Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, Matsuo S: Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 15:1289–1299, 2004PubMed
103.
go back to reference Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y: Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165(10):5767–5772, 2000PubMed Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y: Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165(10):5767–5772, 2000PubMed
104.
go back to reference Mendez-Samperio P, Palma J, Vazquez A: Roles of intracellular calcium and NF-κB in the Bacillus Calmette-Guerin-induced secretion of interleukin-8 from human monocytes. Cell Immunol 211(2):113–122, 2001PubMed Mendez-Samperio P, Palma J, Vazquez A: Roles of intracellular calcium and NF-κB in the Bacillus Calmette-Guerin-induced secretion of interleukin-8 from human monocytes. Cell Immunol 211(2):113–122, 2001PubMed
105.
go back to reference Nakayama K, Furusu A, Xu Q, Konta T, Kitamura M: Unexpected transcriptional induction of monocytes chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J Immunol 167(3):1145–1150, 2001PubMed Nakayama K, Furusu A, Xu Q, Konta T, Kitamura M: Unexpected transcriptional induction of monocytes chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J Immunol 167(3):1145–1150, 2001PubMed
106.
go back to reference Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC: Curcumin, a compound with anti-inflammatory and anti-oxidant properties, downregulates chemokine expression in bone marrow stromal cells. Exp Hematol 25(5):413–422, 1997PubMed Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC: Curcumin, a compound with anti-inflammatory and anti-oxidant properties, downregulates chemokine expression in bone marrow stromal cells. Exp Hematol 25(5):413–422, 1997PubMed
107.
go back to reference Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC: Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11:49–62, 1998 Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC: Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11:49–62, 1998
108.
go back to reference Watanabe A, Takeshita A, Kitano S, Hanazawa S: CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 64(11):4488–4494, 1996PubMed Watanabe A, Takeshita A, Kitano S, Hanazawa S: CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 64(11):4488–4494, 1996PubMed
109.
go back to reference Kobayashi T, Hashimoto S, Horie T: Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54(7):819–824, 1997PubMed Kobayashi T, Hashimoto S, Horie T: Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54(7):819–824, 1997PubMed
110.
go back to reference Gupta B, Ghosh B: Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21(11):745–757, 1999PubMed Gupta B, Ghosh B: Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21(11):745–757, 1999PubMed
111.
go back to reference Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH: Inhibitory effects of curcumin on in vitro lipooxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51(3):813–819, 1991PubMed Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH: Inhibitory effects of curcumin on in vitro lipooxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51(3):813–819, 1991PubMed
112.
go back to reference Tunstall RG, Sharma RA, Perkins S, Sale S, Singh R, Farmer PB, Steward WP, Gescher AJ: Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials. Eur J Cancer 42(3):415–421, 2006PubMed Tunstall RG, Sharma RA, Perkins S, Sale S, Singh R, Farmer PB, Steward WP, Gescher AJ: Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials. Eur J Cancer 42(3):415–421, 2006PubMed
113.
go back to reference Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ: Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation. Carcinogenesis 24:1515–1524, 2003PubMed Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ: Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation. Carcinogenesis 24:1515–1524, 2003PubMed
114.
go back to reference Lee KW, Kim JH, Lee HJ, Surh YJ: Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7(11–12):1612–1620, 2005PubMed Lee KW, Kim JH, Lee HJ, Surh YJ: Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7(11–12):1612–1620, 2005PubMed
115.
go back to reference Su CC, Chen GW, Lin JG, Wu LT, Chung JG: Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26(2A):1281–1288, 2006PubMed Su CC, Chen GW, Lin JG, Wu LT, Chung JG: Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26(2A):1281–1288, 2006PubMed
116.
go back to reference Park C, Kim GY, Kim GD, Choi BT, Park YM, Choi YH: Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15(5):1225–1231, 2006PubMed Park C, Kim GY, Kim GD, Choi BT, Park YM, Choi YH: Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15(5):1225–1231, 2006PubMed
117.
go back to reference Atsumi T, Murakami Y, Shibuya K, Tonosaki K, Fujisawa S: Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. Anticancer Res 25(6B):4029–4036, 2005PubMed Atsumi T, Murakami Y, Shibuya K, Tonosaki K, Fujisawa S: Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. Anticancer Res 25(6B):4029–4036, 2005PubMed
118.
go back to reference Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ, Sharma RA: Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 10(12):1295–1299, 2001PubMed Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ, Sharma RA: Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 10(12):1295–1299, 2001PubMed
119.
go back to reference Moon Y, Glasgow WC, Eling TE: Curcumin suppresses interleukin 1β-mediated microtonal prostaglandin E syntheses 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther 315(2):788–795, 2005PubMed Moon Y, Glasgow WC, Eling TE: Curcumin suppresses interleukin 1β-mediated microtonal prostaglandin E syntheses 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther 315(2):788–795, 2005PubMed
120.
go back to reference Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334(2):313–318, 2005PubMed Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334(2):313–318, 2005PubMed
121.
go back to reference Jiang H, Deng CS, Zhang M, Xia J: Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 12(24):3848–3853, 2006PubMed Jiang H, Deng CS, Zhang M, Xia J: Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 12(24):3848–3853, 2006PubMed
122.
go back to reference Shishodia S, Potdar P, Gairola CG, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaB alpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24(7):1269–1279, 2003PubMed Shishodia S, Potdar P, Gairola CG, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaB alpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24(7):1269–1279, 2003PubMed
123.
go back to reference Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R: Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 228(1):1–15, 2006PubMed Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R: Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 228(1):1–15, 2006PubMed
124.
go back to reference Cho JW, Park K, Kweon GR, Jang BC, Baek WK, Suh MH, Kim CW, Lee KS, Suh SI: Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 37(3):186–912, 2005PubMed Cho JW, Park K, Kweon GR, Jang BC, Baek WK, Suh MH, Kim CW, Lee KS, Suh SI: Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 37(3):186–912, 2005PubMed
125.
go back to reference Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18(44):6013–6020, 1999PubMed Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18(44):6013–6020, 1999PubMed
126.
go back to reference Goel A, Boland CR, Chauhan DP: Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172(2):111–118, 2001PubMed Goel A, Boland CR, Chauhan DP: Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172(2):111–118, 2001PubMed
127.
go back to reference Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS: Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25(9):1671–1679, 2004PubMed Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS: Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25(9):1671–1679, 2004PubMed
128.
go back to reference Chan MM, Ho CT, Huang HI: Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96(1):23–29, 1995PubMed Chan MM, Ho CT, Huang HI: Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96(1):23–29, 1995PubMed
129.
go back to reference Chan MM, Huang HI, Fenton MR, Fong D: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55(12):1955–1962, 1998PubMed Chan MM, Huang HI, Fenton MR, Fong D: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55(12):1955–1962, 1998PubMed
130.
go back to reference Brouet I, Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206(2):533–540, 1995PubMed Brouet I, Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206(2):533–540, 1995PubMed
131.
go back to reference Singh S, Aggarwal BB: Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270(42):24995–25000, 1995PubMed Singh S, Aggarwal BB: Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270(42):24995–25000, 1995PubMed
132.
go back to reference Shishodia S, Amin HM, Lai, R, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70:700–771, 2005PubMed Shishodia S, Amin HM, Lai, R, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70:700–771, 2005PubMed
133.
go back to reference Brennan P, O’Neill LA: Inhibition of nuclear factor kappaB by direct modification in whole cells—mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 55(7):965–973, 1998PubMed Brennan P, O’Neill LA: Inhibition of nuclear factor kappaB by direct modification in whole cells—mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 55(7):965–973, 1998PubMed
134.
go back to reference Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334(2):313–318, 2005PubMed Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334(2):313–318, 2005PubMed
135.
go back to reference Grandjean-Laquerriere A, Gangloff SC, Le Naour R, Trentesaux C, Hornebeck W, Guenounou M: Relative contribution of NF-kB and Ap-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18(3):68–77, 2002 Grandjean-Laquerriere A, Gangloff SC, Le Naour R, Trentesaux C, Hornebeck W, Guenounou M: Relative contribution of NF-kB and Ap-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18(3):68–77, 2002
136.
go back to reference Han SS, Keum YS, Seo HJ, Surh YJ: Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35(3):337–342, 2002PubMed Han SS, Keum YS, Seo HJ, Surh YJ: Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35(3):337–342, 2002PubMed
137.
go back to reference Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX: Preventive and therapeutic effects of NF-κB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 11(12):1747–1752, 2005PubMed Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX: Preventive and therapeutic effects of NF-κB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 11(12):1747–1752, 2005PubMed
138.
go back to reference Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21(21):8370–8377, 2001PubMed Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21(21):8370–8377, 2001PubMed
139.
go back to reference Giri RK, Rajagopal V, Kalra VK: Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91(5):1199–1210, 2004PubMed Giri RK, Rajagopal V, Kalra VK: Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91(5):1199–1210, 2004PubMed
140.
go back to reference Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7):5892–5901, 2005PubMed Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7):5892–5901, 2005PubMed
141.
go back to reference Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M: Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer’s disease patients. J Alzheimers Dis 10:1–7, 2006PubMed Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M: Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer’s disease patients. J Alzheimers Dis 10:1–7, 2006PubMed
142.
go back to reference Natarajan C, Bright JJ: Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168(12):6506–6513, 2002PubMed Natarajan C, Bright JJ: Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168(12):6506–6513, 2002PubMed
143.
go back to reference Nirmala C, Puvanakrishnan R: Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 159(2):85–93, 1996PubMed Nirmala C, Puvanakrishnan R: Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 159(2):85–93, 1996PubMed
144.
go back to reference Dikshit M, Rastogi L, Shukla R, Srimal RC: Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res 101:131–135, 1995 Dikshit M, Rastogi L, Shukla R, Srimal RC: Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res 101:131–135, 1995
145.
go back to reference Cheng H, Liu W, Ai X: Protective effect of curcumin on myocardial ischemia reperfusion injury in rats. Zhong Yao Cai 28(10):920–922, 2005PubMed Cheng H, Liu W, Ai X: Protective effect of curcumin on myocardial ischemia reperfusion injury in rats. Zhong Yao Cai 28(10):920–922, 2005PubMed
146.
go back to reference Yao QH, Wang DQ, Cui CC, Yuan ZY, Chen SB, Yao XW, Wang JK, Lian JF: Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. Biol Pharm Bull 27(2):198–202, 2004PubMed Yao QH, Wang DQ, Cui CC, Yuan ZY, Chen SB, Yao XW, Wang JK, Lian JF: Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. Biol Pharm Bull 27(2):198–202, 2004PubMed
147.
go back to reference Chai H, Yan S, Lin P, Lumsden AB, Yao Q, Chen C: Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J Am Coll Surg 200(6):8208–8230, 2005 Chai H, Yan S, Lin P, Lumsden AB, Yao Q, Chen C: Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J Am Coll Surg 200(6):8208–8230, 2005
148.
go back to reference Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57(1):41–52, 2002PubMed Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57(1):41–52, 2002PubMed
149.
go back to reference Srivivasan A, Menon VP, Periaswamy V, Rajasekaran KN: Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 6(3):327–333, 2003PubMed Srivivasan A, Menon VP, Periaswamy V, Rajasekaran KN: Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 6(3):327–333, 2003PubMed
150.
go back to reference Babu PS, Srinivasan K: Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152(1):13–21, 1995PubMed Babu PS, Srinivasan K: Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152(1):13–21, 1995PubMed
151.
go back to reference Babu PS, Srinivasan K: Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166(1–2):169–175, 1997PubMed Babu PS, Srinivasan K: Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166(1–2):169–175, 1997PubMed
152.
go back to reference Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, Takahashi K, Kawada T, Nakagawa K, Kitahara M: Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 28(5):937–939, 2005PubMed Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, Takahashi K, Kawada T, Nakagawa K, Kitahara M: Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 28(5):937–939, 2005PubMed
153.
go back to reference Murugan P, Pari L: Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci 79(18):1720–1728, 2006PubMed Murugan P, Pari L: Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci 79(18):1720–1728, 2006PubMed
154.
go back to reference Ram A, Das M, Ghosh B: Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 26(7):1021–1024, 2003PubMed Ram A, Das M, Ghosh B: Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 26(7):1021–1024, 2003PubMed
155.
go back to reference Suzuki M, Nakamura T, Iyoki S, Fujiwara A, Watanabe Y, Mohri K, Isobe K, Ono K, Yano S: Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull 28(8):1438–1443, 2005PubMed Suzuki M, Nakamura T, Iyoki S, Fujiwara A, Watanabe Y, Mohri K, Isobe K, Ono K, Yano S: Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull 28(8):1438–1443, 2005PubMed
156.
go back to reference Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K: Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 285(1):G235–G243, 2003PubMed Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K: Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 285(1):G235–G243, 2003PubMed
157.
go back to reference Holt PR, Katz S, Kirshoff R: Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50(11):2191–2193, 2005PubMed Holt PR, Katz S, Kirshoff R: Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50(11):2191–2193, 2005PubMed
158.
go back to reference Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM, Timmermann BN: Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod 69:351–355, 2006PubMed Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM, Timmermann BN: Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod 69:351–355, 2006PubMed
159.
go back to reference Jackson JK, Higo T, Hunter WL, Burt HM: The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 55:168–175, 2006PubMed Jackson JK, Higo T, Hunter WL, Burt HM: The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 55:168–175, 2006PubMed
160.
go back to reference Shoskes D: Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 66:147–152, 1998PubMed Shoskes D: Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 66:147–152, 1998PubMed
161.
go back to reference Shahed AR, Jones E, Shoskes D: Quercetin and curcumin up-regulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. Transplant Proc 33:2988, 2001PubMed Shahed AR, Jones E, Shoskes D: Quercetin and curcumin up-regulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. Transplant Proc 33:2988, 2001PubMed
162.
go back to reference Heng MC, Song MK, Harker J, Heng MK: Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143:937–949, 2000PubMed Heng MC, Song MK, Harker J, Heng MK: Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143:937–949, 2000PubMed
163.
go back to reference Bosman B: Testing of lipooxygenase inhibitors, cyclooxigenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7, 324–334, 1994PubMedCrossRef Bosman B: Testing of lipooxygenase inhibitors, cyclooxigenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7, 324–334, 1994PubMedCrossRef
164.
go back to reference Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, Hoffman S: Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase Cε. Respir Cell Mol Biol 31(1):28–35, 2004 Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, Hoffman S: Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase Cε. Respir Cell Mol Biol 31(1):28–35, 2004
165.
go back to reference Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90(5):1839–1842, 1993PubMed Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90(5):1839–1842, 1993PubMed
166.
go back to reference Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E: Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 149(1):43–52, 1998PubMed Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E: Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 149(1):43–52, 1998PubMed
167.
go back to reference Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR: Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1(6):415–422, 1993PubMed Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR: Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1(6):415–422, 1993PubMed
168.
go back to reference Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49(8):1165–1170, 1995PubMed Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49(8):1165–1170, 1995PubMed
169.
go back to reference Vajragupta O, Boonchoong P, Morris GM, Olson AJ: Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett 15(14):3364–3368, 2005PubMed Vajragupta O, Boonchoong P, Morris GM, Olson AJ: Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett 15(14):3364–3368, 2005PubMed
170.
go back to reference Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK: Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279(49):51163–51171, 2004PubMed Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK: Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279(49):51163–51171, 2004PubMed
Metadata
Title
“Spicing Up” of the Immune System by Curcumin
Authors
Ganesh Chandra Jagetia
Bharat B. Aggarwal
Publication date
01-01-2007
Published in
Journal of Clinical Immunology / Issue 1/2007
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9066-7

Other articles of this Issue 1/2007

Journal of Clinical Immunology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.